American Hospital Association January 9, 2023
Evusheld may not prevent COVID-19 in immunocompromised individuals exposed to the XBB.1.5 omicron subvariant, because the treatment has failed to neutralize similar subvariants, the Food and Drug Administration announced Friday. While it awaits additional data to verify this, FDA recommends health care providers inform patients about this risk, and advise them to test for COVID-19...